Krystal Biotech, Inc.
KRYS
$346.17
-$1.92-0.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 845.63M | 823.41M | 827.79M | 731.07M | 681.99M |
| Total Receivables | 138.66M | 127.02M | 127.43M | 129.63M | 111.44M |
| Inventory | 45.56M | 42.65M | 40.48M | 37.63M | 31.04M |
| Prepaid Expenses | 29.80M | 26.67M | 28.91M | 27.32M | 16.88M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.06B | 1.02B | 1.02B | 925.65M | 841.35M |
|
|
|||||
| Total Current Assets | 1.06B | 1.02B | 1.02B | 925.65M | 841.35M |
| Net Property, Plant & Equipment | 160.60M | 160.62M | 158.02M | 156.32M | 158.04M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.11M | 23.12M | 23.11M | 25.01M | 197.00K |
| Total Assets | 1.50B | 1.40B | 1.33B | 1.24B | 1.14B |
|
|
|||||
| Total Accounts Payable | 6.54M | 4.09M | 3.24M | 2.10M | 7.12M |
| Total Accrued Expenses | 100.67M | 84.84M | 81.25M | 74.08M | 66.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.81M | 1.80M | 1.77M | 1.70M | 1.62M |
| Total Finance Division Other Current Liabilities | 18.38M | 17.07M | 16.69M | 13.39M | 11.51M |
| Total Other Current Liabilities | 18.38M | 17.07M | 16.69M | 13.39M | 11.51M |
| Total Current Liabilities | 127.40M | 107.80M | 102.94M | 91.27M | 86.90M |
|
|
|||||
| Total Current Liabilities | 127.40M | 107.80M | 102.94M | 91.27M | 86.90M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.05M | 7.31M | 7.57M | 7.81M | 8.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.08M | 5.12M | 3.72M | 3.14M | 2.79M |
| Total Liabilities | 141.52M | 120.24M | 114.23M | 102.22M | 97.75M |
|
|
|||||
| Common Stock & APIC | 1.23B | 1.20B | 1.19B | 1.16B | 1.15B |
| Retained Earnings | 134.86M | 80.10M | 24.16M | -27.24M | -106.60M |
| Treasury Stock & Other | -4.34M | -1.62M | 1.14M | 1.10M | 1.16M |
| Total Common Equity | 1.36B | 1.28B | 1.22B | 1.14B | 1.04B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.36B | 1.28B | 1.22B | 1.14B | 1.04B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.36B | 1.28B | 1.22B | 1.14B | 1.04B |
|
|
|||||